Sevoflurane Concentrations in Children
Launched by STATE UNIVERSITY OF NEW YORK AT BUFFALO · Jul 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a drug called sevoflurane, which is used for anesthesia during surgeries in children. Researchers want to understand how different concentrations of sevoflurane affect children when they are first put to sleep for elective surgeries. They will observe and record the sevoflurane levels and vital signs of the children for the first 10 minutes after the anesthesia begins.
To participate in this trial, children must be between 2 and 7 years old and scheduled for a surgery that requires general anesthesia. They should be generally healthy according to specific medical guidelines. However, children with certain health conditions, like severe breathing problems or specific muscle disorders, cannot join. If a child is eligible, their parents will give consent, and the child will be monitored closely during the procedure to ensure their safety. This study aims to improve how anesthesia is used in young patients, making surgeries safer for them.
Gender
ALL
Eligibility criteria
- • Inclusion
- • scheduled for elective surgery under general anesthesia,
- • ASA physical status 1 or 2
- Exclusion Criteria:
- • parents refuse consent
- • presence of moderate or severe cardiorespiratory disease
- • difficult airway
- • malignant hyperthermia
- • neuromuscular disorders
- • obesity
- • obstructive sleep apnea
About State University Of New York At Buffalo
The State University of New York at Buffalo (SUNY Buffalo) is a prominent research institution dedicated to advancing healthcare through innovative clinical trials and studies. Renowned for its commitment to academic excellence and interdisciplinary collaboration, the university leverages its extensive resources and expertise to explore novel therapeutic approaches and enhance patient outcomes. SUNY Buffalo's clinical trials encompass a wide range of medical disciplines, driven by a mission to translate research discoveries into practical applications that benefit diverse populations. With a focus on ethical standards and rigorous methodologies, the university fosters an environment that supports cutting-edge research while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Buffalo, New York, United States
Patients applied
Trial Officials
Jerrold Lerman, MD, FRCPC
Principal Investigator
Great lakes anesthesiology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported